| __timestamp | ImmunityBio, Inc. | Merck & Co., Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1595000 | 7180000000 |
| Thursday, January 1, 2015 | 11434000 | 6704000000 |
| Friday, January 1, 2016 | 26546000 | 7194000000 |
| Sunday, January 1, 2017 | 39778000 | 9982000000 |
| Monday, January 1, 2018 | 53418000 | 9752000000 |
| Tuesday, January 1, 2019 | 111997000 | 9872000000 |
| Wednesday, January 1, 2020 | 139507000 | 13397000000 |
| Friday, January 1, 2021 | 195958000 | 12245000000 |
| Saturday, January 1, 2022 | 248149000 | 13548000000 |
| Sunday, January 1, 2023 | 232366000 | 30531000000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Merck & Co., Inc. and ImmunityBio, Inc. have demonstrated contrasting approaches to R&D investment.
Merck, a titan in the industry, has consistently allocated substantial resources to R&D. In 2023, Merck's R&D expenses soared to nearly $30 billion, marking a 300% increase from 2014. This unwavering commitment underscores Merck's strategy to maintain its leadership through innovation.
In contrast, ImmunityBio, a smaller player, has shown a remarkable growth trajectory in its R&D spending. From a modest $1.6 million in 2014, its investment surged to over $230 million by 2023, reflecting a staggering 14,000% increase. This growth highlights ImmunityBio's ambition to carve out a niche in the biotech landscape.
Who Prioritizes Innovation? R&D Spending Compared for Merck & Co., Inc. and Insmed Incorporated
Research and Development Expenses Breakdown: Merck & Co., Inc. vs Opthea Limited
Analyzing R&D Budgets: Merck & Co., Inc. vs Apellis Pharmaceuticals, Inc.
Comparing Innovation Spending: Merck & Co., Inc. and ADMA Biologics, Inc.
R&D Insights: How Merck & Co., Inc. and Arrowhead Pharmaceuticals, Inc. Allocate Funds
Research and Development Expenses Breakdown: Merck & Co., Inc. vs Dynavax Technologies Corporation
R&D Insights: How Biogen Inc. and ImmunityBio, Inc. Allocate Funds
Viatris Inc. or ImmunityBio, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs ImmunityBio, Inc.
Research and Development: Comparing Key Metrics for Blueprint Medicines Corporation and ImmunityBio, Inc.
ImmunityBio, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for ImmunityBio, Inc. and Mesoblast Limited